The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kyburz, D.
Right arrow Articles by Carson, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kyburz, D.
Right arrow Articles by Carson, D. A.
The Journal of Immunology, 1999, 163: 3116-3122.
Copyright © 1999 by The American Association of Immunologists

Human Rheumatoid Factor Production Is Dependent on CD40 Signaling and Autoantigen1

Diego Kyburz, Maripat Corr, Diana C. Brinson, Amila Von Damm, Helen Tighe and Dennis A. Carson2

Department of Medicine and The Sam and Rose Stein Institute for Research on Aging, University of California at San Diego, La Jolla, CA 92093.

High-affinity pathologic rheumatoid factor (RF) B cells occur in autoimmune diseases such as rheumatoid arthritis, but are deleted in healthy individuals. The reasons for the survival and differentiation of these autoreactive B cells in rheumatoid arthritis are not known. Previous studies in mice transgenic for a human IgM RF have shown that peripheral encounter with soluble human IgG leads to deletion of high-affinity RF B cells; however, deletion can be prevented when concomitant T cell help is provided. This study aimed to further discern the minimal factors necessary not only for the in vivo survival of RF B cells, but also for their differentiation into Ab-secreting cells. The combination of MHC class II-reactive T cells and Ag induced the production of RF in human IgM RF transgenic mice, while either stimulus alone was ineffective. Neutralizing Abs against CD40 ligand (CD40L), but not against IL-4 or IL-15, abrogated IgM-RF production. Moreover, blockade of CD40L-CD40 allowed IgG to delete the RF precursor cells. Most importantly, activating Abs to CD40 could substitute entirely for T cell help in promoting the survival of RF precursors and in stimulating RF synthesis in T cell deficient animals. The data indicate that CD40 signaling alone can prevent deletion of RF B cells by Ag and in the presence of IgG is sufficient to trigger RF synthesis. The results suggest that selective induction of apoptosis in high-affinity RF B cells may be achieved by blockade of CD40L-CD40 interaction.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Hayashi, C. S. Gray, M. Chan, R. I. Tawatao, L. Ronacher, M. A. McGargill, S. K. Datta, D. A. Carson, and M. Corr
Prevention of autoimmune disease by induction of tolerance to Toll-like receptor 7
PNAS, February 24, 2009; 106(8): 2764 - 2769.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. E. Munroe and G. A. Bishop
A Costimulatory Function for T Cell CD40
J. Immunol., January 15, 2007; 178(2): 671 - 682.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
J. C. W. Edwards and G. Cambridge
Prospects for B-cell-targeted therapy in autoimmune disease
Rheumatology, February 1, 2005; 44(2): 151 - 156.
[Full Text] [PDF]


Home page
CVIHome page
D. Daoussis, A. P. Andonopoulos, and S.-N. C. Liossis
Targeting CD40L: a Promising Therapeutic Approach
Clin. Vaccine Immunol., July 1, 2004; 11(4): 635 - 641.
[Full Text]


Home page
Rheumatology (Oxford)Home page
J. C. W. Edwards and G. Cambridge
Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes
Rheumatology, February 1, 2001; 40(2): 205 - 211.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.